Filing Details

Accession Number:
0001104659-18-066381
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-11-06 17:20:49
Reporting Period:
2018-11-02
Accepted Time:
2018-11-06 17:20:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1649904 Rhythm Pharmaceuticals Inc. RYTM () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1615726 H.t. Leonardus Ploeg Der Van 500 Boylston Street, 11Th Floor
Boston MA 02116
Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-11-02 8,200 $4.59 60,539 No 4 M Direct
Common Stock Acquisiton 2018-11-02 10,000 $6.14 70,539 No 4 M Direct
Common Stock Acquisiton 2018-11-02 10,000 $7.52 80,539 No 4 M Direct
Common Stock Disposition 2018-11-02 38,000 $30.09 42,539 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Disposition 2018-11-02 8,200 $0.00 8,200 $4.59
Common Stock Employee Stock Option (Right to Buy) Disposition 2018-11-02 10,000 $0.00 10,000 $6.14
Common Stock Employee Stock Option (Right to Buy) Disposition 2018-11-02 10,000 $0.00 10,000 $7.52
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
33,471 2025-11-16 No 4 M Direct
55,430 2027-04-04 No 4 M Direct
30,894 2025-12-30 No 4 M Direct
Footnotes
  1. On November 2, 2018, Mr. Van der Ploeg sold 38,000 shares pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
  2. This transaction was executed in multiple trades at prices ranging from $30.00 to $30.31, inclusive; the price reported above reflects the weighted average sale price. Mr. Van der Ploeg hereby undertakes to provide to the Securities and Exchange Commission staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
  3. The stock options vest and become exercisable in 48 successive, equal monthly installments measured from August 3, 2015.
  4. The stock options vest and become exercisable in 48 successive, equal monthly installments measured from January 6, 2017.
  5. The stock options vest and become exercisable in 48 successive, equal monthly installments measured from August 3, 2015.